Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Obstacles and opportunities to improve antiretroviral regimen access in low-income countries.

Cohn J, Baker B.

Curr HIV/AIDS Rep. 2010 Aug;7(3):161-7. doi: 10.1007/s11904-010-0053-5. Review.

PMID:
20532837
2.

Current and future management of treatment failure in low- and middle-income countries.

Boyd MA.

Curr Opin HIV AIDS. 2010 Jan;5(1):83-9. doi: 10.1097/COH.0b013e328333b8c0. Review.

PMID:
20046152
3.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2. Review.

PMID:
18571246
4.

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D.

Curr HIV Res. 2006 Jan;4(1):3-20. Review.

PMID:
16454707
5.

WHO initiatives to increase access to treatment in developing countries.

Elliott R.

Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):57-8. English, French.

PMID:
14740603
6.

Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens.

Renaud-Théry F, Nguimfack BD, Vitoria M, Lee E, Graaff P, Samb B, Perriëns J.

AIDS. 2007 Jul;21 Suppl 4:S89-95.

PMID:
17620758
7.

Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.

Puthanakit T, Bunupuradah T.

Curr Opin HIV AIDS. 2010 Jan;5(1):12-7. doi: 10.1097/COH.0b013e3283339b27. Review.

PMID:
20046143
8.
9.

Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.

Schneider H, Blaauw D, Gilson L, Chabikuli N, Goudge J.

Reprod Health Matters. 2006 May;14(27):12-23.

PMID:
16713875
10.

Current and future antiretroviral treatment options in paediatric HIV infection.

Giaquinto C, Morelli E, Fregonese F, Rampon O, Penazzato M, de Rossi A, D'Elia R.

Clin Drug Investig. 2008;28(6):375-97. Review.

PMID:
18479179
11.

Antiretrovirals: reality or illusion?

Mazin R, Zacarias F.

J Int Assoc Physicians AIDS Care. 1998 Oct;4(10):28-9.

PMID:
11365958
12.

Improving first-line antiretroviral therapy in resource-limited settings.

Ford N, Calmy A.

Curr Opin HIV AIDS. 2010 Jan;5(1):38-47. doi: 10.1097/COH.0b013e3283339b41. Review.

PMID:
20046146
13.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
14.

The (political) economics of antiretroviral treatment in developing countries.

Nattrass NJ.

Trends Microbiol. 2008 Dec;16(12):574-9. doi: 10.1016/j.tim.2008.08.012. Epub 2008 Oct 27.

PMID:
18964022
15.
16.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

17.

Strategies to optimize HIV treatment outcomes in resource-limited settings.

Nakanjako D, Colebunders R, Coutinho AG, Kamya MR.

AIDS Rev. 2009 Oct-Dec;11(4):179-89. Review.

PMID:
19940945
18.

Pediatric HIV: new opportunities to treat children.

Van der Linden D, Callens S, Brichard B, Colebunders R.

Expert Opin Pharmacother. 2009 Aug;10(11):1783-91. doi: 10.1517/14656560903012377. Review.

PMID:
19558340
19.

Initiative to promote access to quality HIV medicines releases first batch of results today.

[No authors listed]

J Adv Nurs. 2002 Aug;39(3):215. No abstract available.

PMID:
12174834
20.

Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.

Nachega JB, Mills EJ, Schechter M.

Curr Opin HIV AIDS. 2010 Jan;5(1):70-7. doi: 10.1097/COH.0b013e328333ad61. Review.

PMID:
20046150
Items per page

Supplemental Content

Write to the Help Desk